ImmuCell
ICCC
29 hedge funds and large institutions have $8.53M invested in ImmuCell in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
7% more funds holding
Funds holding: 27 → 29 (+2)
0.38% more ownership
Funds ownership: 12.29% → 12.67% (+0.38%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
7% less capital invested
Capital invested by funds: $9.18M → $8.53M (-$650K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$815K |
| 2 |
BL
Bleichroeder LP
New York
|
+$265K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$14.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.81K |
| 5 |
BlackRock
New York
|
+$7.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Overbrook Management Corp
New York
|
-$89.7K |
| 2 |
Koshinski Asset Management
Decatur,
Illinois
|
-$13.5K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$8.67K |
| 4 |
Renaissance Technologies
New York
|
-$6.87K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWM
26
Geneos Wealth Management
Englewood,
Colorado
| $2K | +$2.12K | +244 | New |
|
27
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $1K | +$1.33K | +153 | New |
|
|
29
Koshinski Asset Management
Decatur,
Illinois
| – | -$13.5K | -1,400 | Closed |
|
30
Wells Fargo
San Francisco,
California
| – | +$26 | +3 | +9% |
|
ICCC Hedge Fund Activity: Q2 2022 in Review
29 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2022, worth a combined $8.53M — down 7.1% from $9.18M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ICCC positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Cresset Asset Management, opening a new position worth an estimated $815K. The largest seller was Overbrook Management Corp, cutting an estimated $89.7K.
- 29 institutional investors held ImmuCell (ICCC) as of Q2 2022, up from 27 in Q1 2022.
- Funds reported $8.53M of ImmuCell stock for Q2 2022, down 7.1% quarter-over-quarter.
- 4 funds opened new ImmuCell positions in Q2 2022 and 1 closed out, a net change of +3 holders.
- The largest ImmuCell buyer in Q2 2022 was Cresset Asset Management, an estimated $815K added.
- The largest ImmuCell seller in Q2 2022 was Overbrook Management Corp, an estimated $89.7K sold.
Based on aggregated 13F filings for Q2 2022.